Caroline O. Michie - Concepedia

Author

Caroline O. Michie

Also Known As

C O Michie, C. Michie, C. O. Michie, C.O. Michie, CO Michie, Caroline Michie, Caroline O Michie, Caroline O. Michie, Caroline Ogilvie Michie, Ciara O'Brien

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Edinburgh Cancer Research Queen's University Belfast Royal Marsden NHS Foundation Trust University of Edinburgh Almac (United Kingdom)

About

Caroline O. Michie is an author at Edinburgh Cancer Research specializing in oncology, medicine, and ovarian cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	149
2	Obstetrics	3	3	121
3	Health Sciences	2	2	28
4	Cell Biology	2	2	57
5	Biochemistry	1	1	18

Caroline O. Michie

Publications

959

Citations

H-Index

Page 1

	Year	Citations
Germline Mutation in <i>BRCA1</i> or <i>BRCA2</i> and Ten-Year Survival for Women Diagnosed with Epithelial Ovarian Cancer Francisco José Cândido dos Reis, Honglin Song, Ellen L. Goode, Clinical Cancer Research	2014	158
Molecular subgroup of high-grade serous ovarian cancer (HGSOC) as a predictor of outcome following bevacizumab. Charlie Gourley, Andrena McCavigan, Timothy Perren, Journal of Clinical Oncology	2014	123
Does shear wave ultrasound independently predict axillary lymph node metastasis in women with invasive breast cancer? Andrew Evans, Petra Rauchhaus, Kim Thomson, Breast Cancer Research and Treatment	2013	109
Expression of glycolytic enzymes in ovarian cancers and evaluation of the glycolytic pathway as a strategy for ovarian cancer treatment Chrysi Xintaropoulou, Carol Ward, Alan Wise, BMC Cancer	2018	102
Increased Incidence of Visceral Metastases in Scottish Patients With BRCA1/2-Defective Ovarian Cancer: An Extension of the Ovarian BRCAness Phenotype Charlie Gourley, Caroline O. Michie, Patricia Roxburgh, Journal of Clinical Oncology	2010	91
BRCA1 is both a prognostic and predictive biomarker of response to chemotherapy in sporadic epithelial ovarian cancer Judith Carser, Jennifer E. Quinn, Caroline O. Michie, Gynecologic Oncology MedicinePathologyGynecologyCancer GenomicsCancer Biology	2011	64
Interim heterogeneity changes measured using entropy texture features on T2-weighted MRI at 3.0 T are associated with pathological response to neoadjuvant chemotherapy in primary breast cancer Shelley Henderson, Colin A. Purdie, Caroline O. Michie, European Radiology	2017	62
Anterior Gradient-3: A novel biomarker for ovarian cancer that mediates cisplatin resistance in xenograft models Terry A. Gray, Nicola J. MacLaine, Caroline O. Michie, Journal of Immunological Methods Cisplatin ResistanceMedicineXenograft ModelsAnterior Gradient-3Cancer Cell Biology	2012	47
High <i>EMSY</i> expression defines a BRCA‐like subgroup of high‐grade serous ovarian carcinoma with prolonged survival and hypersensitivity to platinum Robert L. Hollis, Michael Churchman, Caroline O. Michie, Cancer	2019	40
Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification Robert L. Hollis, Alison Meynert, Caroline O. Michie, Clinical Cancer Research	2022	36

Page 1